BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Staging
6 results:

  • 1. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
    Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
    BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Influence of visceral lipids obesity on the early postoperative complications after radical gastrectomy].
    Qiu GL; Li XW; Wang HJ; Wang PX; Liu JH; Zhu MK; Liao XH; Fan L; Che XM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):596-603. PubMed ID: 35844122
    [No Abstract]    [Full Text] [Related]  

  • 3. The Discordance of Clinical and Pathologic staging in Locally Advanced gastric Adenocarcinoma.
    Papageorge MV; de Geus SWL; Zheng J; Woods AP; Ng SC; Cassidy MR; McAneny D; Tseng JF; Sachs TE
    J Gastrointest Surg; 2021 Jun; 25(6):1363-1369. PubMed ID: 33846934
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical value of carbon nanoparticles tracer in gastric cancer surgery to increase the number of lymph nodes retrieval].
    Cai YQ; Liang YX; Yu SY; Tu RS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):984-989. PubMed ID: 33053994
    [No Abstract]    [Full Text] [Related]  

  • 5. Lymph-nodal ratio in gastric cancer staging system.
    Degiuli M; Borasi A; Forchino F; Marano A; Vendrame A; Casella D; Ponti A; Mussa B; Sandrucci S
    Minerva Chir; 2011 Jun; 66(3):177-82. PubMed ID: 21666553
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
    Bösing NM; Heise JW; Röher HD
    Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.